Glucocorticoids directly regulate testosterone production in Leydig cells through a glucocorticoid receptor (GR)-mediated repression of the genes that encode testosterone biosynthetic enzymes. The extent of this action is determined by the numbers of GR within the Leydig cell, the intracellular concentration of glucocorticoid, and 11␤-hydroxysteroid dehydrogenase (11␤HSD) activities that interconvert corticosterone (in the rat) and its biologically inert derivative, 11-dehydrocorticosterone. As glucocorticoid levels remain stable during pubertal development, GR numbers and 11␤HSD activities are the primary determinants of glucocorticoid action. Therefore, in the present study, levels of GR and 11␤HSD messenger RNA (mRNA) and protein were measured in rat Leydig cells at three stages of pubertal differentiation: mesenchymal-like progenitors (PLC) on day 21, immature Leydig cells (ILC) that secrete 5␣-reduced androgens on day 35, and adult Leydig cells (ALC) that are fully capable of testosterone biosynthesis on day 90. Numbers of GR, measured by [ Although GR binding was lower in PLC, steady state levels for GR mRNA were equivalent at all three stages (P Ͼ 0.05). Oxidative and reductive activities of 11␤HSD were measured by assaying the conversion of radiolabeled substrates in incubations of intact Leydig cells. Both oxidative and reductive activities were barely detectable in PLC, intermediate in ILC, and highest in ALC. The ratio of the two activities favored reduction in PLC and ILC and oxidation in ALC (oxidation/reduction, 0.33 Ϯ 0.33 for PLC, 0.43 Ϯ 0.05 for ILC, and 2.12 Ϯ 0.9 for ALC, with a ratio of 1 indicating equivalent rates for both activities). The mRNA and protein levels of type I 11␤HSD in Leydig cells changed in parallel with 11␤HSD reductive activity, which increased gradually during the transition from PLC to ALC, compared with the sharp rise that was seen in oxidative activity. We conclude that Leydig cells at all developmental stages have GR and that their ability to respond to glucocorticoid diminishes as net 11␤HSD activity switches from reduction to oxidation. This provides a mechanism for the Leydig cell to regulate its intracellular concentration of corticosterone, thereby varying its response to this steroid during pubertal development. (Endocrinology 138: 5089 -5095, 1997) 
Although GR binding was lower in PLC, steady state levels for GR mRNA were equivalent at all three stages (P Ͼ 0.05). Oxidative and reductive activities of 11␤HSD were measured by assaying the conversion of radiolabeled substrates in incubations of intact Leydig cells. Both oxidative and reductive activities were barely detectable in PLC, intermediate in ILC, and highest in ALC. The ratio of the two activities favored reduction in PLC and ILC and oxidation in ALC (oxidation/reduction, 0.33 Ϯ 0.33 for PLC, 0.43 Ϯ 0.05 for ILC, and 2.12 Ϯ 0.9 for ALC, with a ratio of 1 indicating equivalent rates for both activities). The mRNA and protein levels of type I 11␤HSD in Leydig cells changed in parallel with 11␤HSD reductive activity, which increased gradually during the transition from PLC to ALC, compared with the sharp rise that was seen in oxidative activity. We conclude that Leydig cells at all developmental stages have GR and that their ability to respond to glucocorticoid diminishes as net 11␤HSD activity switches from reduction to oxidation. This provides a mechanism for the Leydig cell to regulate its intracellular concentration of corticosterone, thereby varying its response to this steroid during pubertal development. (Endocrinology 138: 5089 -5095, 1997) G LUCOCORTICOIDS play a fundamental role in the differentiation and growth of animal tissues by modulating gene expression (1) . The effects of glucocorticoids are exerted through their receptors (GR), which, when bound to ligand, associate with specific DNA sequences, termed glucocorticoid response elements, that are present in the target gene promoter and either increase or repress transcription (2) . GR can also interfere with the transcriptional activity of factors such as the AP-1 transcription complex by direct protein to protein interactions (3) . The Leydig cell responds to glucocorticoids and is known to contain GR (4, 5) . Although the main function of glucocorticoids in adult Leydig cells is inhibition of testosterone biosynthesis (6 -8) , glucocorticoids may have other functions during Leydig cell development. In this regard, glucocorticoids have been shown to increase the ability of Leydig cell precursors to respond to LH (9) . In addition, GR-modulated genes such as 3␣-hydroxysteroid dehydrogenase (3␣HSD) and insulin-like growth factor I are expressed in Leydig cell precursors (10, 11) ; however, the role of 3␣HSD in the testis has not been determined. Furthermore, the presence of GR in Leydig cell precursors has not been directly established.
11␤HSD, which catalyzes the interconversion of glucocorticoid [corticosterone (CORT) in the rat] and its biologically inert metabolite, 11-dehydrocorticosterone (11DHC), is an important determinant of the intracellular level of bioactive steroid (reviewed in Ref. 12) . Predominance of the oxidative activity results in glucocorticoid inactivation, whereas the reverse reaction, 11␤HSD reduction, has the opposite effect. In organs such as liver and lung, 11␤HSD acts primarily as a reductase, increasing the availability of active glucocorticoids (13, 14) . Recent studies show that reductase activity predominates in both human and rat type I 11␤HSD (15, 16) . In contrast, the other 11␤HSD isoform, type II, has been found to be exclusively oxidative in other organs, such as the kidney, where it lowers glucocorticoid concentrations, preventing this steroid from binding nonspecifically to mineralocorticoid receptors (17) . In humans, the condition of apparent mineralocorticoid excess results from deficient 11␤HSD oxidation, which is believed to be responsible for the abnormal increase in intracellular glucocorticoid; this is associated with mutations in the gene for type II, not type I (reviewed in Ref. 18) .
It has been established that 11␤HSD is a predominant oxidase in freshly isolated intact adult Leydig cells (19) . However, Phillips et al. (20) observed that type I 11␤HSD is abundantly expressed in Leydig cells only after 4 weeks postpartum near the midpoint of puberty. Therefore, it was unclear whether GR-mediated action and glucocorticoid metabolism by 11␤HSD are involved in Leydig cell development. In the present study, we asked whether GR and 11␤HSD messenger RNA (mRNA) and protein are present in Leydig cells undergoing pubertal differentiation. Postnatal development of Leydig cells can be divided conceptually into three distinct stages of differentiation: initially, they exist as mesenchymal-like progenitors (PLC) by day 21; subsequently, as immature Leydig cells (ILC) by day 35, they acquire steroidogenic organelle structure and enzyme activities, but metabolize most of the testosterone that they synthesize; finally, as adult Leydig cells (ALC) by day 90, they actively produce testosterone (reviewed in Ref. 21) . Steady state levels of GR mRNA and numbers of glucocorticoidbinding sites were measured at these three distinct stages, as were 11␤HSD mRNA and oxidative and reductive activities. In contrast to the adult, 11␤HSD net reduction prevailed over oxidation in precursor stages of the Leydig cell.
Materials and Methods Animals
Sprague-Dawley rats (dams with litters of male pups, immature males, and adult males) were purchased from Charles River Laboratories (Wilmington, MA). The males rats were 21, 35, and 90 days of age on the day of cell isolation. The animals were killed by asphyxiation with CO 2 . The animal protocol was approved by the institutional animal care and use committee of the Rockefeller University (Protocol 91200).
Cell isolation
PLC from 20 21-day-old rats, ILC from 15 35-day-old rats, and ALC from six 90-day-old rats were purified as described previously (22) . Purities of Leydig cell fractions were evaluated by histochemical staining for 3␤-hydroxysteroid dehydrogenase activity, with 0.4 mm etiocholanolone as the steroid substrate (23) . In the PLC fraction, approximately 90% of the cells were lightly stained, and of the remaining 10%, 6% were intensely stained. More than 95% ILC and ALC were intensely stained.
[ 3 
H]Dexamethasone binding
The measurement of competitive binding to [ 3 H]dexamethasone was performed using intact Leydig cells as previously described (24) . In brief, Leydig cells were incubated in suspension (1 ϫ 10 6 cells in 0.4 ml) at 34 C for 1 h in phenol red-free Leydig cell medium (DMEM-Ham's F-12), containing 0.78 -50 nm [ 3 H]dexamethasone (DuPont-New England Nuclear, Boston, MA; 46 Ci/mmol). A preliminary study showed that incubation for 1 h was sufficient to reach steady state binding. To correct for nonspecific binding, control tubes were incubated in the presence of a 200-fold excess of unlabeled dexamethasone. After incubation, cells were centrifuged and washed three times with 1.5 ml ice-cold PBS (0.01 m; pH 7.4) containing 1% BSA and pelleted by centrifugation. The cell pellets were lysed with 0.5 ml hyamine hydroxide (ICN Radiochemicals, Irvine, CA), and radioactivity was determined in a ␤-counter.
Determination of 11␤HSD oxidative and reductive activities
11␤HSD oxidative and reductive activities were measured in intact Leydig cells as previously described (25 (26) , was used instead of [ 3 H]CORT. The reaction was stopped by adding 2 ml ice-cold ethyl acetate. The steroids were extracted with ethyl acetate, and the organic layer was dried under nitrogen. The steroids were separated chromatographically on thin layer plates in chloroform-methanol (90: 10), and the radioactivity was measured with a scanning radiometer (System 200/AC3000, Bioscan, Washington DC). The percent conversion of CORT to 11DHC and of 11DHC to CORT was calculated by dividing the radioactive counts identified as 11DHC (or CORT, respectively) by the total counts associated with CORT plus 11DHC.
RT-PCR detection of GR and 11␤HSD mRNAs
Rat GR and 11␤HSD complementary DNA (cDNA) fragments were amplified by RT-PCR using total RNA from Leydig cells according to a previously described procedure (27) . In brief, total RNA was extracted from isolated Leydig cells by a single step method, using phenol and guanidinium thiocyanate (Tri-Reagent, Molecular Research Center, Cincinnati, OH). Leydig cell total RNA (400 ng) was used as the template for avian myeloblastosis virus reverse transcriptase in the presence of random hexamers and deoxyribonucleotides at 42 C for 75 min, and the reaction was terminated by heating at 95 C for 5 min. GR or type I 11␤HSD cDNA was coamplified with ribosomal protein S16 (RPS16) cDNA as an internal standard. PCR was initiated by Taq DNA polymerase in the presence of [␣-
32 P]deoxy-CTP and was allowed to proceed for 30 cycles with an annealing temperature of 50 C. The sequences of primers for GR (forward, 5Ј-TGCAGCAGTGAAATGGGCAA-3Ј; reverse, 5Ј-GGGAATTCAATACTCATGGTC-3Ј) were based on the rat GR cDNA sequence (28) . The primer sequences for type I 11␤HSD (forward, 5Ј-GAAGAAGCATGGAGGTCAAC-3Ј; reverse, 5Ј-CTCAAGATTATC-CCAGAGGT-3Ј) were based on the sequence of rat type I 11␤HSD cDNA (29) . The GR PCR product (533 bp) was confirmed by sequence analysis. The identity of the PCR product for type I (288 bp) 11␤HSD was confirmed by restriction enzyme analysis after digestion with FokI. Primer sequences for RPS16 were reported previously (27) . Radioactive PCR bands were visualized on autoradiographic film (Eastman Kodak, Rochester, NY). Quantitative analysis of mRNA levels was performed by scanning the films with a densitometer (Ultrascan, LKB, Bromma, Sweden). The films were exposed and developed so that the optical densities of bands fell within a linear gray scale on the response curve. The background signals from the blank areas of the films were subtracted from the specific, band-associated signals, after which the signal intensities for GR and type I 11␤HSD were normalized to RPS16.
Western blot analysis of type I 11␤HSD
Leydig cells were homogenized and boiled in equal volumes of sample loading buffer, a Tris-Cl buffer (pH 6.8) containing 20% glycerol, 5% SDS, 3.1% dithiothreitol, and 0.001% bromophenol blue. Homogenized samples (25 g protein) of PLC, ILC, and ALC and a positive control, liver, were electrophoresed on 10% polyacrylamide gels containing SDS (30) . Proteins were electrophoretically transferred onto nitrocellulose membranes, and after 30-min exposure to 10% nonfat milk to block nonspecific binding, the membranes were incubated with a 1:2000 dilution of a rabbit polyclonal antitype I 11␤HSD antibody (no. 56-127) that was generated by immunizing animals (31) with type I 11␤HSD purified from rat liver. The membranes were then washed and incubated with a 1:2000 dilution of goat antirabbit antiserum that was conjugated to horseradish peroxidase. The washing step was repeated, and immunoreactive bands were visualized by chemiluminescence using a kit (ECL, Amersham, Arlington Heights, IL). Protein levels were measured by densitometry of the films as described for PCR band analysis and normalized to liver type I 11␤HSD.
Data analysis
In each experiment, data were obtained from triplicate assays, and the results are expressed as the mean Ϯ se. The dissociation constants (K d ) and the maximal binding (B max ) for [ 3 H]dexamethasone in Leydig cells were estimated by calculation of the Scatchard plots of the ratio of the amount of ligand bound (B) to the amount of free ligand (F) on the y-axis against the amount of B on the x-axis (32) . Statistical analysis of the changes in [ 3 H]dexamethasone-binding sites and 11␤HSD oxidative and reductive activities was performed by Kruskal-Wallis ANOVA followed by multiple comparisons testing to identify significant differences between groups (33) . Statistical analysis of the relative levels of GR mRNA and type I 11␤HSD mRNA and protein was performed after arcsin transformation of the ratio data (31).
Results [ 3 H]Dexamethasone-binding sites and GR mRNA in Leydig cells
To determine whether precursors in the Leydig cell lineage contain GR, intact PLC, ILC, and ALC were analyzed for [ 3 H]dexamethasone binding. As shown in Fig. 1a, all (Fig. 1b) A RT-PCR assay was performed to evaluate steady state GR mRNA levels in Leydig cells. A PCR fragment (533 bp in length) generated from rat GR was detected in all three stages of Leydig cell. Quantification of the results was possible because the RT-PCR assays were performed under conditions that produced a linear range of specific amplification of GR mRNA (data not shown). After normalization to RPS16, steady state mRNA levels for GR were equivalent in all three stages of the Leydig cell (Fig. 2) . It is unlikely, therefore, that the number of GR is transcriptionally regulated.
11␤HSD oxidative and reductive activities in Leydig cells
The response of Leydig cells to glucocorticoid depends not only on the number of GR and the circulating concentration of glucocorticoid, but also on the ratio of 11␤HSD oxidative and reductive activities (12) . When oxidation predominates over reduction, 11␤HSD decreases the intracellular availability of active glucocorticoid, attenuating GR-mediated responses. In contrast, if reductive activity predominated over oxidation, 11␤HSD would facilitate responses to glucocorticoid (13, 14) . Therefore, 11␤HSD oxidative and reductive activities were measured in the presence of endogenous cofactors. Both 11␤HSD oxidative and reductive activities were low in PLC. Both activities increased during Leydig cell differentiation, and were highest in ALC. Oxidative activities were 0.06 Ϯ 0.06 pmol/min⅐10 6 cells (mean Ϯ se) for PLC, 0.52 Ϯ 0.06 for ILC, and 4.74 Ϯ 0.19 for ALC. Reductive activities were 0.18 Ϯ 0.08 for PLC, 1.21 Ϯ 0.13 for ILC, and 2.23 Ϯ 0.18 for ALC (Fig. 3) . Although 11␤HSD oxidative and reductive activities both increased from PLC to ILC, the magnitudes of the increases were different. 11␤HSD reduction was favored in PLC and ILC, as demonstrated by ratios of oxidative to reductive activity (0.33 Ϯ 0.33 in PLC and 0.43 Ϯ 0.05 in ILC; with a ratio of 1 indicating equivalent rates for both activities). In contrast, 11␤HSD oxidation was favored over reduction in ALC by a ratio of 2.13 Ϯ 0.09. These results suggested that 11␤HSD oxidative and reductive activities varied independently of one another during Leydig cell differentiation. Moreover, 11␤HSD reductive activity predominated in Leydig cell precursors, whereas in ALC, the enzyme was primarily oxidative.
Developmental changes in type I 11␤HSD mRNA and protein in Leydig cells
Previous studies showed that Leydig cells contain type I, but not type II 11␤HSD (25, 34, 35) . As type I 11␤HSD is known to have both oxidative and reductive activities, its mRNA levels were measured in the three stages of the Leydig cell. A PCR fragment (288 bp in length) was detected and confirmed by restriction enzyme analysis to be type I. Quan- tification of type I 11␤HSD mRNA was performed under conditions generating a linear range of amplification (data not shown). After normalization to RPS16, the steady state mRNA levels for type I 11␤HSD were found to increase developmentally, being lowest in PLC, intermediate in ILC, and highest in ALC (Fig. 4) . Type II 11␤HSD mRNA levels were undetectable in all stages of Leydig cells (data not shown).
To evaluate further whether type I 11␤HSD protein is associated with 11␤HSD reductive activity in Leydig cells, identical amounts of total protein from PLC, ILC, and ALC were immunoblotted using antitype I 11␤HSD antibody (no. 56-127) and normalized to a positive control liver (Fig. 5) . As shown in Table 1 , the increase in type I mRNA and protein in Leydig cells corresponded closely to 11␤HSD reductive activity during the transitions from PLC to ILC and from ILC to ALC. The same did not hold true for oxidative activity, which increased disproportionately during the transition from ILC to ALC. This suggested that type I 11␤HSD contributes both oxidative and reductive activities in the precursor stages of Leydig cells, with the reductive activity being predominant. The large increase in 11␤HSD oxidative activity seen in ALC could either result from a novel isoform expressed in the mature stage in addition to type I (25) or through posttranslational modification of the type I protein.
Discussion
The results of the present study show that Leydig cells have GR from early stages of differentiation and have increased capacity for 11␤HSD oxidation in the later stages. A discrepancy was observed between GR mRNA levels, which did not change, and the number of glucocorticoid-binding sites, which showed a large increase between days 21 and 35. It is possible that increased Leydig cell expression of heat shock protein-90 is responsible for the developmental rise in GR binding, because this protein is needed for GR binding activity (36, 37) .
The high levels of GR in ILC on day 35 indicate that ILC can respond to glucocorticoid at a time when bioactive CORT reaches its highest serum concentrations (38) . Activities of 11␤HSD activities were higher in ILC than in PLC, and 11␤HSD reductive activity predominated over oxidation. As with other tissues in which type I 11␤HSD is postulated to increase concentrations of active glucocorticoid (13, 14) , reductive activity was predominant in prepubertal Leydig cells. The high intracellular concentration of CORT resulting from 11␤HSD activity in precursor stages of the Leydig cell is significant in light of studies showing that glucocorticoids potentiate the sensitivity of prepubertal Leydig cells to LH (9) and stimulate the expression of 5␣-reductase and 3␣HSD (39, 40) , enzymes that are transiently elevated during Leydig cell differentiation (10, 41) . The transient rise in 5␣-reductase and 3␣HSD expression leads to secretion of 5␣-reduced androgens by precursor stages of the Leydig cell (reviewed in Ref. 21) . In adult Leydig cells, however, glucocorticoids inhibit testosterone production. Therefore, the predominance in oxidative 11␤HSD activity, as we have shown, would be required to inactivate CORT and lower expression of 5␣-reductase and 3␣HSD (10, 30) .
The present data show that 11␤HSD oxidative and reductive activities have distinct developmental trends in Leydig cells. As type II 11␤HSD is exclusively oxidative, the reductive activity can only originate from type I 11␤HSD. Accordingly, we examined the relationship between 11␤HSD reductive activity and the amount of the type I isoform in differentiating Leydig cells. The trends for 11␤HSD reductive activity and type I mRNA and protein were parallel, indicating that 11␤HSD reductive activity is conferred by this isoform. In contrast, the predominance of 11␤HSD oxidation in adult Leydig cells is difficult to reconcile with the enzymatic properties of the two known isoforms. Previous studies demonstrated that adult Leydig cells contain type I 11␤HSD mRNA and protein (19, 25) and NADPH-dependent 11␤HSD reductive activity (25) . If adult Leydig cells contained type I alone, 11␤HSD reductive activity should predominate, as has been shown for liver, lung, uterus (13) (14) (15) (16) , and cell lines transfected with type I 11␤HSD cDNA (42, 43) . Type II 11␤HSD is a high affinity NAD-dependent oxidase, but is not detected in adult Leydig cells by Northern blot, in situ hybridization (34, 35), or RT-PCR (25) . We have recently shown that ALC contain a high affinity (K m ϭ 41 nm) NADPdependent 11␤HSD in addition to low affinity oxidative and reductive activities that are typical of type I (25) . A high affinity NADP-dependent 11␤HSD in adult Leydig cells would account for the predominance of oxidative activity in the enzyme at the physiological levels of glucocorticoids; under conditions of stress CORT levels (Ͼ100 nm), this low capacity component becomes saturated, and the high capacity type I 11␤HSD reductase would then predominate (25, 44) .
A low K m , NADP-dependent 11␤HSD with exclusively oxidative activity is also present in sheep kidney and the choriocarcinoma cell line, JEG-3 (45, 46) . The presence of a high affinity NADP-dependent 11␤HSD oxidative activity could result from the presence of a third isoform or from posttranslational modification of type I 11␤HSD: type I 11␤HSD is a glycosylated protein, and glycosylation of the correct amino acid residues is required for full enzymatic activity. Mutation in the first potential N-linked glycosylation site (asparagine-X-serine, residues 158 -160) had a negligible effect on dehydrogenase activity, but caused a 50% decline in reductive activity. Mutations in the second site (asparagine-X-serine, residues 203-205) completely abolished both activities of the enzyme (47).
In conclusion, GR exist in Leydig cells at all three stages of pubertal development. The presence of GR and the predominance of 11␤HSD reductive activity in prepubertal Leydig cells may be important for their differentiation. The switch in the predominant direction of catalysis of 11␤HSD from reduction to oxidation in adult Leydig cells may protect this cell type from glucocorticoid-mediated inhibition of steroidogenesis. In this way, testosterone production is maintained in the presence of normal serum concentrations of corticosterone and is inhibited only if 11␤HSD oxidative capacity in Leydig cells is exceeded by high levels of corticosterone under stress conditions. 
The number of samples is in parentheses. Within each row, shared alphabet letters refer to groups that were not significantly different at P Ͻ 0.05.
